252 related articles for article (PubMed ID: 24659887)
1. Useful biomarkers for assessment of hepatitis C virus infection-associated autoimmune disorders.
Yang DH; Ho LJ; Lai JH
World J Gastroenterol; 2014 Mar; 20(11):2962-70. PubMed ID: 24659887
[TBL] [Abstract][Full Text] [Related]
2. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.
Himoto T; Masaki T
Clin Dev Immunol; 2012; 2012():871401. PubMed ID: 22988469
[TBL] [Abstract][Full Text] [Related]
3. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in HCV infected patients at Sharkia Governerate, Egypt.
Mahrous S; Mangoud A; Eissa M; Sabee E; Amin I; Ismail A; Morsy T; Afefy A; el-Shorbagy E; Nour Eldin E; Mostafa Y; Abouel-Magd Y; el-Sadawy M; Ragab H; Hassan M; Lakouz K; Abdel-Aziz K; Saber M; el-Hady G
J Egypt Soc Parasitol; 2004 Apr; 34(1 Suppl):429-46. PubMed ID: 15124751
[TBL] [Abstract][Full Text] [Related]
5. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.
Cacoub P; Poynard T; Ghillani P; Charlotte F; Olivi M; Piette JC; Opolon P
Arthritis Rheum; 1999 Oct; 42(10):2204-12. PubMed ID: 10524695
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
7. HCV infection: pathogenesis, clinical manifestations and therapy.
Antonelli A; Ferri C; Galeazzi M; Giannitti C; Manno D; Mieli-Vergani G; Menegatti E; Olivieri I; Puoti M; Palazzi C; Roccatello D; Vergani D; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S39-47. PubMed ID: 18570753
[TBL] [Abstract][Full Text] [Related]
8. [Auto-immune serological disorders in chronic viral C hepatitis: prevalence and clinical significance].
Mouelhi L; Debbeche R; Sfar I; Salem M; Bouzaidi S; Trabelsi S; Gorgi Y; Najjar T
Tunis Med; 2008 Sep; 86(9):777-81. PubMed ID: 19472775
[TBL] [Abstract][Full Text] [Related]
9. Anti-C-reactive protein antibodies in chronic hepatitis C infection: correlation with severity and autoimmunity.
Kessel A; Elias G; Pavlotzky E; Zuckerman E; Rosner I; Toubi E
Hum Immunol; 2007 Oct; 68(10):844-8. PubMed ID: 17961773
[TBL] [Abstract][Full Text] [Related]
10. Rheumatic manifestations of hepatitis C virus infection are associated with autoantibodies but not viremia.
Weng MT; Chang TH; Lin CC; Wu CS
J Microbiol Immunol Infect; 2023 Aug; 56(4):739-746. PubMed ID: 37055257
[TBL] [Abstract][Full Text] [Related]
11. Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.
Stefanova-Petrova DV; Tzvetanska AH; Naumova EJ; Mihailova AP; Hadjiev EA; Dikova RP; Vukov MI; Tchernev KG
World J Gastroenterol; 2007 Dec; 13(48):6518-28. PubMed ID: 18161922
[TBL] [Abstract][Full Text] [Related]
12. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.
Cacoub P; Renou C; Rosenthal E; Cohen P; Loury I; Loustaud-Ratti V; Yamamoto AM; Camproux AC; Hausfater P; Musset L; Veyssier P; Raguin G; Piette JC
Medicine (Baltimore); 2000 Jan; 79(1):47-56. PubMed ID: 10670409
[TBL] [Abstract][Full Text] [Related]
13. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
14. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions.
Valentini G; Mantelli A; Persico M; Tuccillo C; Del Vecchio Blanco G; Morisco F; Improta RD; Migliaresi S; Gualdieri L; Caporaso N
Clin Exp Rheumatol; 1999; 17(1):75-9. PubMed ID: 10084036
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in chronic liver disease.
Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
[TBL] [Abstract][Full Text] [Related]
16. HCV-related autoimmune disorders in HCV chronic infection.
Ferrari SM; Fallahi P; Mancusi C; Colaci M; Manfredi A; Ferri C; Antonelli A
Clin Ter; 2013; 164(4):e305-12. PubMed ID: 24045529
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Lunel F; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
[TBL] [Abstract][Full Text] [Related]
19. Anti-SSB/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection.
Wu CS; Hu CY; Hsu PN
Clin Rheumatol; 2008 Mar; 27(3):365-8. PubMed ID: 17992468
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.
Fadda SH; Bassyouni IH; Hamdy A; Foad NA; Wali IE
Immunol Invest; 2015; 44(1):45-55. PubMed ID: 25028787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
